About the Journal of Dermatologic Research and Therapy
Advancing dermatologic science through rigorous peer-reviewed research that bridges discovery and therapy—trusted by researchers, clinicians, and translational scientists worldwide.
Advancing Dermatologic Research and Therapy
The Journal of Dermatologic Research and Therapy (JDRT) (ISSN 2471-2175) is a peer-reviewed, open access publication dedicated to advancing knowledge across the spectrum of dermatologic science—from molecular mechanisms to clinical and translational applications. As a journal that adheres to COPE's publication ethics guidelines and is supported by Open Access Pub, JDRT provides a rigorous platform for research that deepens understanding of skin pathophysiology while also supporting therapeutic innovation, including biomarker development, target identification, and treatment strategies.
Our editorial mission centers on three pillars: scientific depth supported by robust experimental design, transparent peer review that ensures methodological rigor, and rapid dissemination under Creative Commons licensing. We publish multidisciplinary investigations spanning molecular dermatology, disease pathway analysis, biomarker discovery, translational models, and clinically relevant therapeutic research that bridges laboratory findings with real-world applications.
JDRT serves researchers, clinicians, and scientists exploring the biology of skin disease—from inflammatory cascades and immune dysregulation to oncogenic signaling and barrier dysfunction. Our community includes molecular biologists, dermatopathologists, immunologists, geneticists, pharmaceutical scientists, and clinical dermatologists committed to understanding both how diseases develop and how they can be effectively treated.
Dermatologic research operates at the intersection of molecular biology, immunology, genetics, systems pathology, and clinical practice. JDRT provides a specialized publishing home for investigations that dissect disease mechanisms and advance therapeutic solutions with scientific precision. Our editorial board—comprising pathophysiologists, molecular immunologists, genomics experts, translational researchers, and clinical dermatologists—evaluates submissions through a lens of scientific insight, reproducibility, and relevance to both research and therapy.
Each manuscript undergoes rigorous peer review focused on experimental design, data interpretation, statistical validity, and scientific or clinical significance. Accepted articles receive structured formatting, DOI assignment, indexing support, and promotional amplification designed to maximize impact across the dermatological research and clinical communities.
JDRT publishes high-quality research that advances understanding of dermatologic conditions through mechanistic, translational, and clinical investigations. We welcome studies that explore molecular pathways, disease models, biomarker validation, and therapeutic development.
Molecular pathways in psoriasis, atopic dermatitis, contact dermatitis; cytokine networks, immune cell trafficking, barrier dysfunction mechanisms.
Oncogenic signaling in melanoma, basal cell carcinoma, squamous cell carcinoma; tumor microenvironment, metastatic mechanisms, resistance pathways.
Molecular basis of pemphigus, pemphigoid, lupus erythematosus; autoantibody mechanisms, complement activation, epitope mapping.
Monogenic skin disorders, genotype-phenotype correlations, gene expression profiling, epigenetic regulation of skin homeostasis.
Cellular and molecular mechanisms of tissue repair, scarring pathways, keloid formation, regenerative signaling cascades.
Host-pathogen interactions in bacterial, viral, fungal skin infections; immune evasion mechanisms, virulence factor analysis.
Novel diagnostic, prognostic, and mechanistic biomarkers; proteomic and genomic signatures; validation studies in disease models.
Organoid models, 3D skin equivalents, animal models of skin disease; validation of translational research platforms.
Molecular targets for therapeutic intervention, pathway modulation studies, mechanism-of-action investigations for novel compounds.
JDRT employs single-blind peer review as standard. Our reviewers are selected based on expertise in specific scientific and clinical domains, ensuring that each manuscript receives specialized evaluation of its contribution to dermatologic research and therapy.
- Scientific Rigor: Reviewers assess experimental design, control selection, data reproducibility, and the validity of interpretations, whether mechanistic or clinical.
- Statistical Integrity: Quantitative analyses are evaluated for appropriate methodology, statistical power, and transparent reporting of results.
- Ethical Compliance: All submissions must document institutional approvals, adherence to animal research guidelines, and appropriate biosafety protocols.
- Reproducibility Standards: Manuscripts should provide sufficient methodological detail for independent replication, including reagent specifications and procedural parameters.
- Constructive Feedback: Reviews emphasize scientific improvement, offering guidance to strengthen clarity, interpretation, and translational or clinical relevance.
JDRT recognizes that research teams operate under competing demands. Our submission system is designed for efficiency while maintaining scientific rigor.
Pre-Submission Review
Consult Aims & Scope and Author Instructions to ensure alignment with JDRT's focus on both research and therapy. Verify that ethical approvals, animal protocols, and biosafety documentation are complete.
Manuscript Preparation
Structure your manuscript with clear hypotheses, detailed methods, quantitative results, and discussion focused on pathophysiological or therapeutic implications. Include supplementary data, reagent catalogs, and statistical analysis files.
Submission
Submit via the online portal, Manuscript Zone, or email to [email protected]. Editorial acknowledgment is provided within 72 hours.
Peer Review
Manuscripts undergo evaluation by 2–3 experts in relevant scientific or clinical domains. First decisions are typically rendered within 18 days, with revision timelines tailored to experimental or clinical complexity.
Publication
Accepted manuscripts proceed to copyediting, proof approval (48-hour author review), and online publication within 3 days of final acceptance. Articles receive DOI assignment, indexing metadata, and promotional support.
JDRT publishes under Creative Commons Attribution 4.0 (CC BY 4.0), ensuring unrestricted access to scientific and clinical discoveries. Authors retain copyright while enabling global dissemination for research, teaching, and therapeutic applications.
We encourage authors to deposit datasets, protocols, and supplementary materials in public repositories (Zenodo, Dryad, Figshare, OSF, or domain-specific archives). Data availability statements are mandatory, and sharing practices align with FAIR principles. Review our data archiving policies for detailed guidance.
Article processing charges apply only upon acceptance. Waivers are available for authors from lower-income countries and early-career researchers. Contact our editorial office to discuss eligibility.
JDRT articles are indexed across academic databases, library systems, and scientific search platforms to maximize discoverability by the global dermatological research and clinical communities.
- Academic Databases: Google Scholar, Semantic Scholar, Crossref, ResearchGate, Academia.edu
- Specialized Indexes: Scilit, ResearchBib, CiteFactor, SciSpace, IP Indexing, SJIF, Cosmos Impact Factor
- University Collections: Catalogued by institutions including University of Birmingham, Wageningen University, Nottingham Trent University, and Victoria University
- Repository Presence: CORE (The Open University), Bayreuth University Library, and regional consortia
Authors receive post-publication support including social media promotion, thematic collection inclusion, and assistance with institutional repository deposits. Monitor new publications via the current issue or explore historical content in the archives.
Advance Dermatological Science with JDRT
Whether your research decodes disease mechanisms, develops novel therapies, or bridges discovery with clinical application, JDRT provides a rigorous platform for impactful science. Partner with an editorial team committed to scientific integrity, methodological excellence, and global research and therapeutic impact.
